Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

25 Apr 2013 07:00

RNS Number : 1743D
Biome Technologies PLC
25 April 2013
 



25 April 2013

 

Biome Technologies plc

("Biome", "the Company" or "the Group")

 

Trading Update

 

In advance of its Annual General Meeting today, Biome Technologies plc is pleased to announce its trading update for the three months ended 31 March 2013.

 

Trading Update

Total Group revenues achieved for the first three months of the year were £0.4m (Q1 2012: £4.6m including contributions from Biotec). We anticipate performance this year to be second half weighted and consequently expect sales growth to increase in both divisions as the year progresses.

 

The Group's cash position at 31st March 2013 was £5.8m (31st December 2012: £6.3m).

 

We continue to make progress with the strategy, as set out at our full year results, to commercialise and develop wholly owned intellectual property. and our performance remains in line with the Board's expectations.

 

Bioplastics Division

Q1 2013 revenues were £0.2m (Q1 2012: £4.3m including contributions from Biotec). This division is focused on developing high margin, application led products with enhanced level of functionality. Two key projects currently being undertaken include single use foodservice products and single use coffee capsules. These projects are progressing well and their contribution to revenues will become clearer during the second half of the year when they are expected to pass into a predominantly manufacturing phase.

 

In the first quarter, the division was awarded a grant by the Government-backed Technology Strategy Board (TSB) to investigate a bio-based alternative for the oil derived organic chemicals used in the manufacture of bioplastics. The £150,000 grant has been made to Biome Technologies as part of the TSB's 'Sustainable high value chemical manufacture through industrial biotechnology' competition, which funds projects that apply sustainable biobased feedstocks and biocatalytic processes for the production of chemicals. Biome has partnered with the University of Warwick's Centre for Biotechnology and Biorefining to work on the feasibility study that will be funded by this grant.

 

Stanelco RF Technologies Division

Q1 revenues were £0.2m (Q1 2012: £0.3m). This Division continues to see a wider variety of opportunities opening up as the business develops. As previously reported, a number of optical fibre furnace deliveries have been delayed due to some uncertainties in the Chinese fibre market although this market is expected to return to growth during the course of the year. Progress continues on the Durapipe project and the timing of delivery for ten pre-production units will be finalised over the next quarter, following time-based testing of the final pipe-work.

 

Stephen Baskerville, will be joining the Group to head up the Division as its Managing Director in August. Stephen joins the business following some twenty years in technical and commercial roles within the industry, most recently as Director of Heating Products at Inductotherm Heating and Welding Limited, a subsidiary of the global Inductotherm Group.

 

 

- Ends -

 

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

www.biometechnologiesplc.com Tel: +44 (0) 2380 867 100

 

 

Daniel Stewart & Company plc

David Hart

www.danielstewart.co.uk Tel: +44 (0) 20 7776 6550

 

First Columbus

Chris Crawford/Kelly Gardiner

www.first-columbus.com Tel: +44 (0) 20 3002 2070

 

 

FTI Consulting

Oliver Winters/Latika Shah Tel: +44 (0) 20 7831 3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTNKQDKFBKDDQB
Date   Source Headline
27th Mar 20192:05 pmRNSSecond Price Monitoring Extn
27th Mar 20192:00 pmRNSPrice Monitoring Extension
13th Mar 20191:54 pmRNSHoldings in Company
24th Jan 20197:00 amRNSPre-close Trading Statement
31st Dec 20187:00 amRNSTotal Voting Rights
10th Dec 20182:35 pmRNS2017 Long Term Incentive Plan - First Vesting
6th Dec 20187:00 amRNSGrant funding from Innovate UK
23rd Nov 201812:38 pmRNSBiome to present at Mello London
1st Nov 20187:00 amRNSTrading update
3rd Sep 20187:00 amRNSInterim Results
23rd Jul 20187:00 amRNSTrading Update
31st May 20185:00 pmRNSTotal Voting Rights
2nd May 20184:13 pmRNSIssue of shares to directors & PDMR shareholdings
2nd May 20183:27 pmRNSProposed issue of shares to directors and dealings
24th Apr 201810:40 amRNSResult of Annual General Meeting
24th Apr 20187:00 amRNSTrading update
28th Mar 20181:52 pmRNSNotice of AGM and Annual Report and Accounts
27th Mar 20187:00 amRNSPreliminary Results
19th Feb 20182:05 pmRNSSecond Price Monitoring Extn
19th Feb 20182:00 pmRNSPrice Monitoring Extension
25th Jan 20187:00 amRNSPre-close Trading Statement
21st Dec 20177:00 amRNSNew LTIP and option grant
1st Nov 20177:00 amRNSTrading Update
4th Sep 20177:00 amRNSHalf-year Report
26th Jul 20179:30 amRNSDirector/PDMR Shareholding
25th Jul 20174:50 pmRNSDirector/PDMR Shareholding
24th Jul 20177:00 amRNSTrading Update
24th Apr 201710:45 amRNSResult of AGM
24th Apr 20177:00 amRNSTrading Update
31st Mar 20172:50 pmRNSNotice of AGM and Annual Report and Accounts
29th Mar 20177:00 amRNSPreliminary Results
20th Jan 20177:00 amRNSPre-close Trading Statement
18th Jan 20177:00 amRNSSettlement Agreement
2nd Nov 20167:00 amRNSTrading Update
31st Aug 20167:00 amRNSHalf-year Report
27th Jun 20167:00 amRNSTrading Update
25th Apr 201612:34 pmRNSResult of Annual General Meeting
25th Apr 20167:00 amRNSTrading Update
1st Apr 201610:42 amRNSNotice of AGM and Annual Report and Accounts
30th Mar 20167:00 amRNSFinal Results
26th Jan 20167:00 amRNSPre-close Trading Statement
3rd Nov 20157:00 amRNSTrading Statement
2nd Sep 20157:00 amRNSInterim Results
23rd Jul 20157:00 amRNSTrading Update
19th Jun 20159:00 amRNSNew Contract
27th Apr 20154:46 pmRNSResult of AGM
27th Apr 20157:00 amRNSTrading Update
27th Mar 20153:43 pmRNSNotice of Annual General Meeting
25th Mar 20157:00 amRNSPreliminary Results
19th Feb 20153:26 pmRNSFunding Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.